EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk

Jose Marcos Sanches, Li Na Zhao iD, Albert Salehi iD, Claes B Wollheim iD, Philipp Kaldis iD

The FEBS Journal · 2023-02 · 290 (3) · 620-648

DOI: 10.1111/febs.16306 ↗

At a glance

Übersichtsarbeit in The FEBS Journal, published online on 2021-12-09. Written by Jose Marcos Sanches and 4 co-authors. Institution: Department of Clinical Sciences, Lund University, Malmö, Sweden. Major MEDLINE topics: Diabetes Mellitus, Type 2, Insulin Resistance. Cited 109 times so far (Crossref); 309 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Faculty of Medicine, Swedish Research Council, Lund University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Diabetes is a complex and multifactorial disease that affects millions of people worldwide, reducing the quality of life significantly, and results in grave consequences for our health care system. In type 2 diabetes (T2D), the lack of β‐cell compensatory mechanisms overcoming peripherally developed insulin resistance is a paramount factor leading to disturbed blood glucose levels and lipid metabolism. Impaired β‐cell functions and insulin resistance have been studied extensively resulting in a good understanding of these pathways but much less is known about interorgan crosstalk, which we define as signaling between tissues by secreted factors. Besides hormones and organokines, dysregulated blood glucose and long‐lasting hyperglycemia in T2D is associated with changes in metabolism with metabolites from different tissues contributing to the development of this disease. Recent data suggest that metabolites, such as lipids including free fatty acids and amino acids, play important roles in the interorgan crosstalk during the development of T2D. In general, metabolic remodeling affects physiological homeostasis and impacts the development of T2D. Hence, we highlight the importance of metabolic interorgan crosstalk in this review to gain enhanced knowledge of the pathophysiology of T2D, which may lead to new therapeutic approaches to treat this disease.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceHumansBlood GlucoseQuality of LifeAmino Acids

Author keywords

diabetesfree fatty acidsinflammationinterorgan crosstalklivermetabolitesmetabolomicsorganokinestype 2 diabetes

Substances

Blood GlucoseAmino Acids

Authors and institutions

  • Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.

ORCID profiles: Li Na Zhao, Albert Salehi, Claes B Wollheim, Philipp Kaldis

Funding

  • Faculty of Medicine
  • Swedish Research Council
  • Lund University
  • Swedish Foundation for Strategic Research
  • Swedish Diabetes Foundation
  • IngaBritt och Arne Lundbergs Forskningsstiftelse

Cite

APA

Sanches, J. M., Zhao, L. N., Salehi, A., Wollheim, C. B., & Kaldis, P. (2023). Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. The FEBS Journal, 290(3), 620-648. https://doi.org/10.1111/febs.16306

Vancouver

Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. The FEBS Journal. 2023;290(3):620-648. doi:10.1111/febs.16306

BibTeX
@article{Sanches2023,
  author = {Sanches, Jose Marcos and Zhao, Li Na and Salehi, Albert and Wollheim, Claes B and Kaldis, Philipp},
  title = {Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk},
  journal = {The FEBS Journal},
  year = {2023},
  volume = {290},
  number = {3},
  pages = {620--648},
  doi = {10.1111/febs.16306}
}
Start for free →